This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia
BMC Cancer Open Access 18 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alkhateeb AA, Connor JR The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta 2013; 1836: 245–254.
Tachibana T, Tanaka M, Numata A, Takasaki H, Ito S, Ohshima R et al. Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk. Leuk Lymphoma 2012; 53: 456–461.
Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK et al. The transplant iron score as a predictor of stem cell transplant survival. J Hematol Oncol 2009; 2: 44.
Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA et al. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant 2010; 45: 1528–1533.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–371.
Tanaka M, Tachibana T, Numata A, Takasaki H, Matsumoto K, Maruta A et al. A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT. Bone Marrow Transplant 2012; 47: 596–597.
Tachibana T, Takasaki H, Tanaka M, Maruta A, Hyo R, Ishigatsubo Y et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011; 46: 150–151.
Armand P Hyperferritinemia in stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 335–337.
Sivgin S, Baldane S, Akyol G, Keklik M, Kaynar L, Kurnaz F et al. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload. Transfusion Apheresis Sci 2013; 49: 295–301.
Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2009; 44: 793–797.
Acknowledgements
This study was supported in part by Grants from the National Natural Science Foundation of China (No.: 30971283, No.: 81170502), the Zhejiang Provincial Natural Science Foundation of China (No.: LZ12H08001), the Creative Team Project of Zhejiang Provincial Bureau of Science and Technology (No.: 2011R50015) and Zhejiang Provincial Fund of Health Bureau (No.: 2007B122).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Wang, Z., Jia, M., Zhao, H. et al. Prognostic impact of pretransplantation hyperferritinemia in adults undergoing allogeneic hematopoietic SCT: a meta-analysis. Bone Marrow Transplant 49, 1339–1340 (2014). https://doi.org/10.1038/bmt.2014.127
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.127